Scinovex
reviewTop 10% cited

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

Cancer Letters · 2004 · Vol. 225(1) · pp. 1–26
James G. ChristensenJon BurrowsRavi Salgia
Liver physiology and pathologyPancreatic function and diabetesOrgan Transplantation Techniques and OutcomesHepatocyte growth factorCancer researchReceptor tyrosine kinaseC-MetBiologyGefitinibCancerTyrosine kinaseCancer cellHepatocyte Growth Factor Receptor

MeSH terms

Proto-Oncogene MasAnimalsCell MovementDisease Models, AnimalGene AmplificationHumansMice, TransgenicMutationNeoplasmsNeovascularization, PathologicPhenotypeHepatocyte Growth FactorProto-Oncogene Proteins c-metCell ProliferationMice
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.